Ying Jin

7.8k citations
138 papers · 4.5k indexed · 4 hit papers · h-index 37

Impact in

    • Cancer-related molecular mechanisms research
    • Cancer Genomics and Diagnostics
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies

Papers in

    • Colorectal Cancer Treatments and Studies 27
    • Lung Cancer Research Studies 18
    • Cancer Immunotherapy and Biomarkers 12
    • Pancreatic and Hepatic Oncology Research 9

Ying Jin

138 papers receiving 4.5k citations

Hit Papers

Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study 2023 · 77 citations
772019202620212023100200300

Peers

Ying Jin
Comparison fields: 5 of 136
  • Cancer Research 1.2k
  • Oncology 1.9k
  • Otorhinolaryngology 294
  • Pulmonary and Respiratory Medicine 1.3k
  • Pathology and Forensic Medicine 479
Replace Satoshi Fujii with:
Satoshi Fujii Japan
Yuhong Li China
Ping Li China
Peter Obrist Austria
Carlos Lopes Portugal
Shilpa Gupta United States
Frank G. Ondrey United States
Roger Stenling Sweden
Martha Quezado United States
Chien‐Feng Li Taiwan
Ying Jin relative to Satoshi Fujii Japan Satoshi Fujii's profile →
Citations per field
00.5×1.5×2.5×
Satoshi Fujii · 1×
Citations per year

Countries citing papers authored by Ying Jin

Since Specialization
Citations

This map shows the geographic impact of Ying Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jin more than expected).

Fields of papers citing papers by Ying Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jin. The network helps show where Ying Jin may publish in the future.

Co-authors

The 25 scholars most cited alongside Ying Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ying Jin Line = papers co-authored together Ying Jin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20242
4 202418
5 20247
6 202330
7 202322
8 20234
9 202159
10 201914
11 20197
12
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
Hit paper breakdown →
2019374
13 20181
14 20164
15
Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
201585
16 201455
17 201352
18 20115
19 2008180
20 19897

About Ying Jin

Ying Jin is a scholar working on Oncology, Otorhinolaryngology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 138 papers that have together received 4.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (27 papers), Gastric Cancer Management and Outcomes (23 papers), Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (18 papers), Cancer Genomics and Diagnostics (17 papers), Cancer Immunotherapy and Biomarkers (12 papers), RNA modifications and cancer (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.9k citations), Otorhinolaryngology (294 citations), Pulmonary and Respiratory Medicine (1.3k citations) and Pathology and Forensic Medicine (479 citations). Ying Jin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Rui‐Hua Xu, Feng Wang, Qi Zhao, Ming-Ming He, Zexian Liu, De‐Shen Wang, Miao‐Zhen Qiu, Hui Luo, Ying-Nan Wang and Yuhong Li. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer, BMC Cancer, Journal of Cancer Research and Clinical Oncology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026